Progression in prediagnostic Huntington disease
Authors:
- 1 September 2009
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 81 (4) , 379-384
Abstract
Objective To examine rates of decline in individuals at risk for Huntington disease (HD). Methods 106 individuals at risk for HD completed a battery of neurocognitive, psychomotor and oculomotor tasks at two visits, approximately 2.5 years apart. Participants were classified as: (1) without the CAG expansion (normal controls, NC; n=68) or (2) with the CAG expansion (CAG+; n=38). The CAG+ group was further subdivided into those near to (near; n=19) or far from (far; n=19) their estimated age of onset. Longitudinal performance in the CAG+ group was evaluated with a repeated measures model with two main effects (time to onset, visit) and their interaction. Analysis of covariance was employed to detect differences in longitudinal performance in the three groups (NC, near and far). Results In the CAG+, the interaction term was significant (p≤0.02) for four measures (movement time, alternate button tapping, variability of latency for a memory guided task and percentage of errors for a more complex memory guided task), suggesting the rate of decline was more rapid as subjects approached onset. Longitudinal progression in the three groups differed for several variables (pConclusions Different patterns of progression were observed during the prediagnostic period. For some measures, CAG+ subjects closer to estimated onset showed a more rapid decline while for other measures the CAG+ group had a constant rate of decline throughout the prediagnostic period that was more rapid than in NC.Keywords
This publication has 35 references indexed in Scilit:
- Ten‐year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington diseaseMovement Disorders, 2008
- Detection of Huntington's disease decades before diagnosis: the Predict-HD studyJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Longitudinal Evaluation of "Presymptomatic" Carriers of Huntington's DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2007
- Evidence for specific cognitive deficits in preclinical Huntington's diseaseBrain, 1998
- Neuropsychological characteristics of Huntington's disease carriers: a double blind study.Journal of Medical Genetics, 1995
- Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease.Journal of Medical Genetics, 1995
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Evidence of presymptomatic cognitive decline in Huntington's diseaseJournal of Clinical and Experimental Neuropsychology, 1992
- Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individualsMovement Disorders, 1990
- VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGEPerceptual and Motor Skills, 1958